Fermenta Biotech Limited has recently informed exchanges that the company’s Active Pharmaceutical Ingredient (API) manufacturing facility in Dahej, Gujarat, India, was awarded a certificate of GMP compliance from the Competent Authority of Germany, after a European Union Good Manufacturing Practice (EU GMP) inspection in March 2024.
This approval indicates the company’s commitment to ensuring that Quality Assurance sticks with the demanding standards of Good Manufacturing Practices.
Fermenta’s Managing Director, Mr. Prashant Nagre said, “We are pleased with the positive outcome of the recent EU GMP inspection at our Dahej Manufacturing Facility in Gujarat. The certificate of GMP compliance underscores our commitment to global standards of quality, compliance and consistency in manufacturing.”
